Xi'An International Medical Investment (000516.SZ) has received approval from the China Securities Regulatory Commission for its application to issue stocks to specific targets.
International Medical (000516.SZ) announced that on September 7, 2026, it received a reply from the China Securities Regulatory Commission regarding the approval of Xi'an International Medical Investment Co., Ltd.'s application for the registration of stock issuance to specific objects, agreeing to the company's registration application for issuing stocks to specific parties.
Xi'An International Medical Investment (000516.SZ) announced that on September 7, 2026, it received a reply from the China Securities Regulatory Commission regarding the approval of Xi'An International Medical Investment Co., Ltd.'s application for the registration of stock issuance to specific targets, agreeing to the company's application for the registration of stock issuance to specific targets.
Related Articles
LONGBIO-B(01779) has been included in the stock lists of the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect.
Jiangsu Tongxingbao Intelligent Transportation Technology (301339.SZ) plans to change its stock abbreviation to Su Jiang Shuzhi.
MICOT PHARMA-B (02335) has been included in the stock connection mechanism (Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect) stock list.
LONGBIO-B(01779) has been included in the stock lists of the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect.
Jiangsu Tongxingbao Intelligent Transportation Technology (301339.SZ) plans to change its stock abbreviation to Su Jiang Shuzhi.
MICOT PHARMA-B (02335) has been included in the stock connection mechanism (Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect) stock list.
RECOMMEND
